Literature DB >> 11158964

Vascular NAD(P)H oxidase is distinct from the phagocytic enzyme and modulates vascular reactivity control.

H P Souza1, F R Laurindo, R C Ziegelstein, C O Berlowitz, J L Zweier.   

Abstract

An NAD(P)H oxidase has been hypothesized to be the main source of reactive oxygen species (ROS) in vessels; however, questions remain about its function and similarity with the neutrophil oxidase. Therefore, vascular superoxide generation was measured by electron paramagnetic resonance spectroscopy using the spin-trap 5,5'-dimethly-pyrroline-N-oxide in aortas from wild-type (WT) and gp91(phox)-deficient mice (gp91(phox)-/-), which do not have a functioning neutrophil NADPH oxidase. There was no significant difference between radical adduct formation by WT or gp91(phox)-/- mouse aortas either at baseline or after stimulation with NADPH or NADH. Also, spin-adduct formation was identical in the 100,000-g pellets obtained from WT and gp91(phox)-/- mouse aortas. SOD mimetics and the flavoenzyme inhibitor diphenyleneiodonium blocked spin-adduct formation from both intact vessels and particulate fractions. Other pharmacological inhibitors of metabolic pathways involved in ROS generation had no effect on this phenomenon. To examine the role of this enzyme in vascular tone control, aortic rings were suspended in organ chambers and preconstricted with phenylephrine to reach half-maximal contraction. Exposure to NADPH elicited a 20% increase in vascular tone, which was decreased by SOD mimetics in a concentration-dependent manner, suggesting that superoxide was responsible for this phenomenon. NADH had no effect on vascular tone. Thus superoxide is generated in the vessel wall by an NAD(P)H-dependent oxidase, which modulates vascular contractile tone. This enzyme is structurally and genetically distinct from the neutrophil NADPH oxidase.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11158964     DOI: 10.1152/ajpheart.2001.280.2.H658

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   4.733


  8 in total

1.  Out, damned dot: studies of the NADPH oxidase in atherosclerosis.

Authors:  K K Griendling; D G Harrison
Journal:  J Clin Invest       Date:  2001-11       Impact factor: 14.808

2.  Disturbed flow-induced FAK K152 SUMOylation initiates the formation of pro-inflammation positive feedback loop by inducing reactive oxygen species production in endothelial cells.

Authors:  Loka Reddy Velatooru; Rei J Abe; Masaki Imanishi; Young Jin Gi; Kyung Ae Ko; Kyung-Sun Heo; Keigi Fujiwara; Nhat-Tu Le; Sivareddy Kotla
Journal:  Free Radic Biol Med       Date:  2021-10-05       Impact factor: 7.376

Review 3.  Redox signaling.

Authors:  Henry Jay Forman; Martine Torres; Jon Fukuto
Journal:  Mol Cell Biochem       Date:  2002 May-Jun       Impact factor: 3.396

4.  Role of NADPH oxidase and iNOS in vasoconstrictor responses of vessels from hypertensive and normotensive rats.

Authors:  Y Alvarez; A M Briones; R Hernanz; J V Pérez-Girón; M J Alonso; M Salaices
Journal:  Br J Pharmacol       Date:  2007-11-12       Impact factor: 8.739

5.  Polyunsaturated fatty acids modulate NOX 4 anion superoxide production in human fibroblasts.

Authors:  Adrien Rossary; Khelifa Arab; Jean-Paul Steghens
Journal:  Biochem J       Date:  2007-08-15       Impact factor: 3.857

6.  Decreased neointimal formation in Nox2-deficient mice reveals a direct role for NADPH oxidase in the response to arterial injury.

Authors:  Zhiping Chen; John F Keaney; Eberhard Schulz; Bruce Levison; Lian Shan; Masashi Sakuma; Xiaobin Zhang; Can Shi; Stanley L Hazen; Daniel I Simon
Journal:  Proc Natl Acad Sci U S A       Date:  2004-08-17       Impact factor: 11.205

7.  Superoxide dismutase mimetic M40403 improves endothelial function in apolipoprotein(E)-deficient mice.

Authors:  Fan Jiang; Yanan Guo; Daniela Salvemini; Gregory J Dusting
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

8.  Dissociation between superoxide accumulation and nitroglycerin-induced tolerance.

Authors:  Pei-Suen Tsou; Vamsi Addanki; Ho-Leung Fung
Journal:  J Pharmacol Exp Ther       Date:  2008-07-24       Impact factor: 4.030

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.